← Back to Search

Skin-to-Skin Contact for Premature Birth

N/A
Waitlist Available
Research Sponsored by Norwegian University of Science and Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)
Be younger than 18 years old
Must not have
Infants who need immediate medical interventions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying the effects of skin-to-skin contact on preterm infants.

Who is the study for?
This trial is for preterm infants born between 28-32 weeks of gestation. It's not suitable for those needing immediate medical interventions after birth.
What is being tested?
The study compares the effects of skin-to-skin contact with standard care in an incubator on preterm infants' physiological and emotional responses, as well as their general movements.
What are the potential side effects?
Since this trial involves non-invasive methods like skin-to-skin contact, there are minimal expected side effects compared to medical or drug interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby was born between 28 and 32 weeks of pregnancy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My infant requires immediate medical care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
cognitive scorer at two years corrected age
Secondary study objectives
Child Behaviour
Developmental skills at two years corrected age
Anxiety
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: skin-to-skinExperimental Treatment1 Intervention
immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours.
Group II: standard careActive Control1 Intervention
after birth the baby is transferred to the neonatal intensive care unit

Find a Location

Who is running the clinical trial?

Norwegian University of Science and TechnologyLead Sponsor
664 Previous Clinical Trials
2,178,109 Total Patients Enrolled
8 Trials studying Premature Birth
1,041 Patients Enrolled for Premature Birth
Drammen sykehusOTHER
14 Previous Clinical Trials
100,909 Total Patients Enrolled
IWK Health CentreOTHER
129 Previous Clinical Trials
112,020 Total Patients Enrolled
5 Trials studying Premature Birth
3,131 Patients Enrolled for Premature Birth
Sorlandet Hospital HFOTHER_GOV
120 Previous Clinical Trials
91,575 Total Patients Enrolled
St. Olavs HospitalOTHER
538 Previous Clinical Trials
307,537 Total Patients Enrolled
7 Trials studying Premature Birth
779 Patients Enrolled for Premature Birth
Håkon Bergseng, md phdStudy DirectorNorwegian University of Science and Technology

Media Library

skin-to-skin Clinical Trial Eligibility Overview. Trial Name: NCT02024854 — N/A
Premature Birth Research Study Groups: skin-to-skin, standard care
Premature Birth Clinical Trial 2023: skin-to-skin Highlights & Side Effects. Trial Name: NCT02024854 — N/A
skin-to-skin 2023 Treatment Timeline for Medical Study. Trial Name: NCT02024854 — N/A
~9 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top